Skip to main content Accessibility help
×
Home

Implications of modifying the duration requirement of generalized anxiety disorder in developed and developing countries

  • S. Lee (a1), A. Tsang (a2), A. M. Ruscio (a3), J. M. Haro (a4), D. J. Stein (a5), J. Alonso (a6), M. C. Angermeyer (a7), E. J. Bromet (a8), K. Demyttenaere (a9), G. de Girolamo (a10), R. de Graaf (a11), O. Gureje (a12), N. Iwata (a13), E. G. Karam (a14), J.-P. Lepine (a15), D. Levinson (a16), M. E. Medina-Mora (a17), M. A. Oakley Browne (a18), J. Posada-Villa (a19) and R. C. Kessler (a20)...

Abstract

Background

A number of western studies have suggested that the 6-month duration requirement of generalized anxiety disorder (GAD) does not represent a critical threshold in terms of onset, course, or risk factors of the disorder. No study has examined the consequences of modifying the duration requirement across a wide range of correlates in both developed and developing countries.

Method

Population surveys were carried out in seven developing and 10 developed countries using the WHO Composite International Diagnostic Interview (total sample=85 052). Prevalence and correlates of GAD were compared across mutually exclusive GAD subgroups defined by different minimum duration criteria.

Results

Lifetime prevalence estimates for GAD lasting 1 month, 3 months, 6 months and 12 months were 7.5%, 5.2%, 4.1% and 3.0% for developed countries and 2.7%, 1.8%, 1.5% and 1.2% for developing countries, respectively. There was little difference between GAD of 6 months' duration and GAD of shorter durations (1–2 months, 3–5 months) in age of onset, symptom severity or persistence, co-morbidity or impairment. GAD lasting ⩾12 months was the most severe, persistently symptomatic and impaired subgroup.

Conclusions

In both developed and developing countries, the clinical profile of GAD is similar regardless of duration. The DSM-IV 6-month duration criterion excludes a large number of individuals who present with shorter generalized anxiety episodes which may be recurrent, impairing and contributory to treatment-seeking. Future iterations of the DSM and ICD should consider modifying the 6-month duration criterion so as to better capture the diversity of clinically salient anxiety presentations.

Copyright

Corresponding author

*Address for correspondence: Professor S. Lee, Director, Hong Kong Mood Disorders Center, 7A, Block E, Staff Quarters, Prince of Wales Hospital, Shatin, NT, Hong Kong. (Email: singlee@cuhk.edu.hk)

References

Hide All
Angst, J, Gamma, A, Joseph Bienvenu, O, Eaton, WW, Ajdacic, V, Eich, D, Rössler, W (2006). Varying temporal criteria for generalized anxiety disorder: prevalence and clinical characteristics in a young age cohort. Psychological Medicine 36, 12831292.
APA (1980). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. American Psychiatric Association: Washington, DC.
APA (1987). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, revised. American Psychiatric Association: Washington, DC.
APA (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revision. American Psychiatric Association: Washington, DC.
Bienvenu, OJ, Nestadt, G, Eaton, WW (1998). Characterizing generalized anxiety: temporal and symptomatic thresholds. Journal of Nervous and Mental Disease 186, 5156.
Breslau, N, Davis, GC (1985). DSM-III generalized anxiety disorder: an empirical investigation of more stringent criteria. Psychiatry Research 15, 231238.
Brown, TA, Di Nardo, PA, Lehman, CL, Campbell, LA (2001). Reliability of DSM-IV anxiety and mood disorders: implications for the classification of emotional disorders. Journal of Abnormal Psychology 110, 4958.
Carter, RM, Wittchen, HU, Pfister, H, Kessler, RC (2001). One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample. Depression and Anxiety 13, 7888.
Chang, SM, Hahm, BJ, Lee, JY, Shin, MS, Jeon, HJ, Hong, JP, Lee, HB, Lee, DW, Cho, MJ (2008). Cross-national difference in the prevalence of depression caused by the diagnostic threshold. Journal of Affective Disorders 106, 159167.
Demyttenaere, K, Bruffaerts, R, Posada-Villa, J, Gasquet, I, Kovess, V, Lepine, JP, Angermeyer, MC, Bernert, S, de Girolamo, G, Morosini, P, Polidori, G, Kikkawa, T, Kawakami, N, Ono, Y, Takeshima, T, Uda, H, Karam, EG, Fayyad, JA, Karam, AN, Mneimneh, ZN, Medina-Mora, ME, Borges, G, Lara, C, de Graaf, R, Ormel, J, Gureje, O, Shen, Y, Huang, Y, Zhang, M, Alonso, J, Haro, JM, Vilagut, G, Bromet, EJ, Gluzman, S, Webb, C, Kessler, RC, Merikangas, KR, Anthony, JC, Von Korff, MR, Wang, PS, Brugha, TS, Aguilar-Gaxiola, S, Lee, S, Heeringa, S, Pennell, BE, Zaslavsky, AM, Ustun, TB, Chatterji, S, WHO World Mental Health Survey Consortium (2004). Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. Journal of the American Medical Association 291, 25812590.
Feighner, JP, Robins, E, Guze, SB, Woodruff, RA Jr., Winokur, G, Munoz, R (1972). Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry 26, 5763.
First, MB, Spitzer, RL, Gibbon, M, Williams, JBW (2002). Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP). Biometrics Research, New York State Psychiatric Institute: New York.
Gureje, O, Lasebikan, VO, Kola, L, Makanjuola, VA (2006). Lifetime and 12-month prevalence of mental disorders in the Nigerian Survey of Mental Health and Well-Being. British Journal of Psychiatry 188, 465471.
Halli, SS, Vaninadha Rao, K (1992). Advanced Techniques of Population Analysis. Plenum Press: New York.
Haro, JM, Arbabzadeh-Bouchez, S, Brugha, TS, de Girolamo, G, Guyer, ME, Jin, R, Lepine, JP, Mazzi, F, Reneses, B, Vilagut, G, Sampson, NA, Kessler, RC (2006). Concordance of the Composite International Diagnostic Interview version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys. International Journal of Methods in Psychiatric Research 15, 167180.
Hettema, JM, Prescott, CA, Kendler, KS (2001). A population-based twin study of generalized anxiety disorder in men and women. Journal of Nervous and Mental Disease 189, 413420.
Heuzenroeder, L, Donnelly, M, Haby, MM, Mihalopoulos, C, Rossell, R, Carter, R, Andrews, G, Vos, T (2004). Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder. Australia and New Zealand Journal of Psychiatry 38, 602612.
Kendler, KS, Neale, MC, Kessler, RC, Heath, AC, Eaves, LJ (1992). Generalized anxiety disorder in women. A population-based twin study. Archives of General Psychiatry 49, 267272.
Kendler, KS, Neale, MC, Kessler, RC, Heath, AC, Eaves, LJ (1994). Clinical characteristics of familial generalized anxiety disorder. Anxiety 1, 186191.
Kessler, RC, Andrade, LH, Bijl, RV, Offord, DR, Demler, OV, Stein, DJ (2002). The effects of comorbidity on the onset and persistence of generalized anxiety disorder in the ICPE surveys. Psychological Medicine 32, 12131225.
Kessler, RC, Brandenburg, N, Lane, M, Roy-Byrne, P, Stang, PD, Stein, DJ, Wittchen, HU (2005). Rethinking the duration requirement for generalized anxiety disorder: evidence from the National Comorbidity Survey Replication. Psychological Medicine 35, 10731082.
Kessler, RC, Ustun, TB (2004). The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). International Journal of Methods in Psychiatric Research 13, 93121.
Knauper, B, Cannell, CF, Schwarz, N, Bruce, ML, Kessler, RC (1999). Improving the accuracy of major depression age of onset reports in the US National Comorbidity Survey. International Journal of Methods in Psychiatric Research 8, 3948.
Lee, S, Tsang, A, Chui, H, Kwok, K, Cheung, E (2007 a). A community epidemiological survey of generalized anxiety disorder in Hong Kong. Community Mental Health Journal 43, 305319.
Lee, S, Tsang, A, Zhang, MY, Huang, YQ, He, YL, Liu, ZR, Shen, YC, Kessler, RC (2007 b). Lifetime prevalence and inter-cohort variation in DSM-IV disorders in metropolitan China. Psychological Medicine 37, 6171.
Leon, AC, Olfson, M, Portera, L, Farber, L, Sheehan, DV (1997). Assessing psychiatric impairment in primary care with the Sheehan Disability Scale. International Journal of Psychiatry in Medicine 27, 93105.
Maier, W, Gansicke, M, Freyberger, HJ, Linz, M, Heun, R, Lecrubier, Y (2000). Generalized anxiety disorder (ICD-10) in primary care from a cross-cultural perspective: a valid diagnostic entity? Acta Psychiatrica Scandinavica 101, 2936.
Rickels, K, Rynn, M (2001). Overview and clinical presentation of generalized anxiety disorder. Psychiatric Clinics of North America 24, 117.
Ruscio, AM (2002). Delimiting the boundaries of generalized anxiety disorder: differentiating high worriers with and without GAD. Journal of Anxiety Disorders 16, 377400.
Ruscio, AM, Chiu, WT, Roy-Byrne, P, Stang, PE, Stein, DJ, Wittchen, HU, Kessler, RC (2007). Broadening the definition of generalized anxiety disorder: effects on prevalence and associations with other disorders in the National Comorbidity Survey Replication. Journal of Anxiety Disorders 21, 662676.
Shen, YC, Zhang, MY, Huang, YQ, He, YL, Liu, ZR, Cheng, H, Tsang, A, Lee, S, Kessler, RC (2006). Twelve-month prevalence, severity, and unmet need for treatment of mental disorders in metropolitan China. Psychological Medicine 36, 257267.
Slade, T, Andrews, G (2001). DSM-IV and ICD-10 generalized anxiety disorder: discrepant diagnoses and associated disability. Social Psychiatry and Psychiatric Epidemiology 36, 4551.
Spitzer, RL, Williams, JBW (1984). Diagnostic issues in the DSM-III classification of the anxiety disorders. In Psychiatry Updates: The American Psychiatric Association Annual Review Volume III (ed. Grinspoon, L.), pp. 392402. American Psychiatric Press: Washington, DC.
United Nations Development Programme (2004). Human Development Report 2004: Cultural Liberty in Today's Diverse World. United Nations Development Programme: New York.
Wang, PS, Angermeyer, MC, Borges, G, Bruffaerts, R, Tat Chiu, W, de Girolamo, G, Fayyad, J, Gureje, O, Haro, JM, Huang, Y, Kessler, RC, Kovess, V, Levinson, D, Nakane, Y, Oakley Brown, MA, Ormel, JH, Posada-Villa, J, Aguilar-Gaxiola, S, Alonso, J, Lee, S, Heeringa, S, Pennell, BE, Chatterji, S, Ustun, TB (2007). Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry 6, 177185.
Wolter, KM (1985). Introduction to Variance Estimation. Springer-Verlag: New York.
WHO (1978). Mental Disorders: Glossary and Guide to their Classification in Accordance with the Ninth Revision of the International Classification of Diseases. World Health Organization: Geneva.
WHO (1993). The ICD-10 Classification of Mental and Behavioural Disorders. World Health Organization: Geneva.
Yonkers, KA, Dyck, IR, Warshaw, M, Keller, MB (2000). Factors predicting the clinical course of generalised anxiety disorder. British Journal of Psychiatry 176, 544549.
Yonkers, KA, Warshaw, MG, Massion, AO, Keller, MB (1996). Phenomenology and course of generalised anxiety disorder. British Journal of Psychiatry 168, 308313.

Keywords

Related content

Powered by UNSILO

Implications of modifying the duration requirement of generalized anxiety disorder in developed and developing countries

  • S. Lee (a1), A. Tsang (a2), A. M. Ruscio (a3), J. M. Haro (a4), D. J. Stein (a5), J. Alonso (a6), M. C. Angermeyer (a7), E. J. Bromet (a8), K. Demyttenaere (a9), G. de Girolamo (a10), R. de Graaf (a11), O. Gureje (a12), N. Iwata (a13), E. G. Karam (a14), J.-P. Lepine (a15), D. Levinson (a16), M. E. Medina-Mora (a17), M. A. Oakley Browne (a18), J. Posada-Villa (a19) and R. C. Kessler (a20)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.